Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD Bank of England Statistics AD Investing.com Markets AD LSEG Data AD CME Group Education
Asset Mgmt

Novo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5%

Trade Hub UK regulation desk (2026-08-05): Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies. Primary source: original at CNBC Finance (cnbc.com).

By CNBC Finance

Novo Nordisk CEO defends economics of Wegovy pill as lower prices weigh on sales; shares fall 5%

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.

Read at source

Read also
  1. Labubu maker Pop Mart shares fall as key ex-China sales data drop, Citi cuts price target
  2. Alibaba shares fall 4% as AI spending drives 75% drop in net income
  3. Lego posts record first-half revenue, CEO touts strong sales at high-end and value pricing
  4. S&P 500: Higher Yields and Oil Prices Cloud the Outlook
  5. Nasdaq 100 Under Pressure From Rising Yields, Oil Prices: What to Watch Today

Source: CNBC Finance